Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000895421-25-000200
Filing Date
2025-02-03
Accepted
2025-02-03 16:36:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7937
2 EXHIBIT NO. 99.1 TO SCHEDULE 13G JOINT FILING AGREEMENT EXHIBIT_NO.99.1.txt EX-99.1 CHARTER 1394
3 EXHIBIT NO. 99.2 ITEM 7 INFORMATION EXHIBIT_NO.99.2.txt EX-99.2 OPIN COUNSEL 685
  Complete submission text file 0000895421-25-000200.txt   12017
Mailing Address 1585 BROADWAY NEW YORK NY 10036
Business Address 1585 BROADWAY NEW YORK NY 10036 212-761-4000
MORGAN STANLEY (Filed by) CIK: 0000895421 (see all company filings)

EIN.: 363145972 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Subject) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91051 | Film No.: 25583091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)